Data integrity failures continue to plague the pharmaceutical industry, casting doubt on product quality years after global regulatory authorities began cracking down on the problem, a US FDA official’s recent analysis of US and EU enforcement actions shows.
The problem is personal for the FDA compliance official, who had to make a potentially life altering decision with a drug product he picked up at a pharmacy after he
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?